GlassScriptPhysician profile
Tanya S Dewitt
NPI 1881753689
$842.12
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $666 · 2020: $62.97 · 2021: $114.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $263.22 | 2019-2021 | |
| Therapeuticsmd, INC. | $236.67 | 2019-2021 | |
| Astellas Pharma US INC | $125.00 | 2019 | |
| Amag Pharmaceuticals, INC. | $61.68 | 2019-2020 | |
| Allergan, INC. | $53.88 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.95 | 2019 | |
| Lupin INC. | $19.59 | 2019 | |
| Vertical Pharmaceuticals, LLC | $18.50 | 2019 | |
| Millicent US INC | $15.88 | 2019 | |
| Exeltis, USA INC. | $15.75 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tanya Dewitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.